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Pancreatic duct glands (PDGs) have molecular features known to mark stem cell niches, but their function remains to be
determined. To investigate the role of PDGs as a progenitor niche, PDGs were analyzed in both humans and mice. Cells were
characterized by immunohistochemistry and microarray analysis. In vivo proliferative activity and migration of PDG cells were
evaluated using a BrdU tag-and-chase strategy in a mouse model of pancreatitis. In vitro migration assays were used to
determine the role of trefoil factor (TFF) -1 and 2 in cell migration. Proliferative activity in the pancreatic epithelium in
response to inflammatory injury is identified principally within the PDG compartment. These proliferating cells then migrate
out of the PDG compartment to populate the pancreatic duct. Most of the pancreatic epithelial migration occurs within 5 days
and relies, in part, on TFF-1 and -2. After migration, PDG cells lose their PDG-specific markers and gain a more mature
pancreatic ductal phenotype. Expression analysis of the PDG epithelium reveals enrichment of embryonic and stem cell
pathways. These results suggest that PDGs are an epithelial progenitor compartment that gives rise to mature differentiated
progeny that migrate to the pancreatic duct. Thus PDGs are a progenitor niche important for pancreatic epithelial
regeneration.
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Maintenance and repair of most epithelia are achieved by
stem cells, which must undergo cell division in order tois an open access article under the CC BY-NC-ND license
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resulting in daughter cells that migrate and differentiate
into multiple lineages of the particular epithelium (Barker
et al., 2010; Blanpain et al., 2007; Potten and Loeffler,
1990). The pancreatic epithelium is thought to have a low
turnover rate under normal physiologic conditions (Grapin-
Botton, 2005; Bonner-Weir and Sharma, 2002); however, it is
capable of rapid regeneration in response to inflammatory
injury (Finegood et al., 1995; Neuschwander-Tetri et al.,
2000). The existence of somatic stem cells and their con-
tribution to pancreatic epithelial renewal and regeneration
after injury are poorly understood.
Perhaps some of the best studied models of epithelial
regeneration from a somatic stem cell niche are in the GI
system (Koo and Clevers, 2014; Español-Suñer et al., 2012;
Williams et al., 2014; Barker, 2014). The liver has a low rate of
cellular turnover but high regenerative potential. Its paren-
chyma relies initially on a mechanism of self-duplication, and
relies on stem cells, ductular oval cells, only when hepatocyte
division is inhibited. In the intestinal system, the epithelial
turnover occurs every 3–5 days, while Paneth cells are
supplied every 3–6 weeks. Epithelial stem cells exist in a
protected microenvironment called niches. These niches
contain several different cell types initially defined by their
proliferative properties: the label retaining cell (LRC), likely
the true stem cell, which normally has a lower rate of division
but can transform into a proliferative and multipotential
stem cell during injury; and the transient amplifying (TA) cell
which is believed to be a direct progeny of the true stem
cell and are capable of division but for a restricted period of
time (Blanpain et al., 2007; Hoffmann, 2008). Despite the
extensive characterization of these stem cell niches in the
colon and small intestine, only a few molecular markers for
these cells have been identified. Several studies strongly
implicate Lgr5 and Lrig1 as markers and regulators of the stem
cell compartment (Barker et al., 2012).
Epithelial regeneration and renewal from progenitor niches
throughout the gastrointestinal system require a complex
balance of proliferation, migration and differentiation. As
newly generated cellsmigrate from the stemcell compartment,
they differentiate to acquire the phenotype of their terminally
differentiated lineages. This migration is regulated, in part, by
the Trefoil Factor Family (TFF) of proteins. There are three
members within this family TFF-1, TFF-2 and TFF-3. All TFFs are
protease resistant proteins, which are best known for their
important roles in epithelial repair after inflammatory injury
(Hoffmann, 2005; Taupin and Podolsky, 2003). The TFFs are
abundantly secreted onto the mucosal surface by
mucus-secreting cells of the gastrointestinal tract and the
pancreatic duct (Ebert et al., 1999; Madsen et al., 2007). In the
stomach the expression of TFF-1 and -2 is rapidly up-regulated
at themargin ofmucosal injury, and their fundamental function
is to promote epithelial repair by cell migration.
The identification of stem cells or progenitor cells, and
their contribution to pancreatic regeneration remain contro-
versial (Ziv et al., 2013; Burke and Tosh, 2012). The pancreas
uses several regenerative mechanisms. Self-renewal is the
principal mechanism of acinar and islet regeneration in
response to inflammatory injury (Strobel et al., 2007a,
2007b; Dor et al., 2004), however, little is known about
pancreatic ductal epithelial renewal. Multipotential stem
cells have been reported to reside in the pancreatic duct(Bonner-Weir and Sharma, 2002), islets, centroacinar or
acinar cells and have the capacity for duct-like cell fates.
(Pan et al., 2013; Rovira et al., 2010; Kopp et al., 2011;
Reichert and Rustgi, 2011; Puri et al., 2015). Recently our
group identified a novel epithelial compartment, termed
pancreatic duct glands (PDGs), which may function as a ductal
epithelial progenitor niche (Strobel et al., 2010). PDGs are
gland-like outpouches or coiled glands residing within the
mesenchymal cuff of surrounding large ducts. PDGs have a
unique molecular profile distinct from glands of the normal
pancreatic epithelium. They also express developmental
markers known to reside in GI progenitor stem cell niches,
such as Shh, Pdx-1 and Hes-1. In response to inflammatory
injury, epithelial proliferation is up-regulated predominantly
in the PDG compartment, suggesting that this may be an
epithelial progenitor compartment for the pancreatic ductal
epithelium.
In this study, we find that the PDGs are the principal site
of ductal proliferation in response to acute inflammatory
injury. Trefoil family factors -1 and -2 (TFF-1, TFF-2) promote
the migration of newly generated cells from PDGs to the
pancreatic ductal epithelium. Furthermore, the PDG com-
partment is enriched for pathways important in embryonic and
GI stem cell niches. These results suggest that PDGs constitute
an epithelial progenitor niche important in the repair of the
pancreatic duct after inflammatory injury.
Methods
Human samples
Human samples were collected and analyzed in accordance
with Institutional Review Board approval. Normal control
pancreata (n = 14) were obtained from organ donors and
chronic pancreatitis samples (n = 20) were obtained from
pancreatectomy specimens at Massachusetts General Hospi-
tal. No patients were included who carried a diagnosis of
IPMN or PDAC.
Mouse samples
All experiments were approved by the Massachusetts General
Hospital Subcommittee on Research Animal Care (SRAC #
2003N000288). Healthy FVB mice (Charles River) served as
control (n = 7). Acute pancreatitis was induced in FVB mice of
either sex by cerulein injection every other day for 8 days
(4 injections) (n = 21). Each series of injections comprised 8
hourly intraperitoneal injections of 50 μg/kg cerulein (Sigma, St
Louis, MO). In vivo pulse labeling was performed by intra-
peritoneal injection of bromodeoxyuridine (BrdU; Sigma) at
1 mg/10 g body weight 24 h after the last cerulein injection.
Pancreata were harvested 2 h after BrdU injection then daily
for 7 days, with additional harvest on day 14 and 21. Positive
and negative nuclei were counted throughout the large
pancreatic duct with multiple slides per mouse; approximately
30 HPF per sample were evaluated to calculate the rate of BrdU
positive cells in the ducts and PDGs. This BrdU tag-and-chase
technique was repeated in TFF2 knockout mice (Baus-Loncar et
al., 2005; Farrell et al., 2002) (n = 12, kind gift of Dr. Wang
(Columbia University)) and evaluated. The pancreata obtained
from Lgr5; EGFP mice (Barker et al., 2007) (n = 4) were
Table 1 Conditions and primary antibodies for immunohistochemistry.
Protein of interest Species Antibody by Clone Concentration
TFF1 Human Invitrogen BC04 1:50
TFF1 Human and mouse Abcam ab50806 1:200
TFF2 Human Novocastra GE16C 1:50
TFF2 Human and mouse Protein Tech 1:500
MUC6 Human Novocastra NCL-MUC-6 1:100
Deep gastric mucin (MUC6) Mouse Dr. Ho 1:3000
KRT7 Human and mouse Abcam RCK105 1:50
Ki67 Human Dako MIB-1 1:100
Ki67 Mouse Dako TEC3 1:25
Ki67 Mouse Abcam ab16667 1:100
BrdU Mouse Abcam ab6326 1:100
192 J. Yamaguchi et al.evaluated to investigate the existence of Lgr5 in the PDG
compartment.
Histology and immunohistochemistry
Specimens were fixed overnight in 10% formalin/phosphate-
buffered saline. Histological analysis was performed on 4 μm
paraffin-embedded sections. Primary antibodies and condi-
tions for immunohistochemistry are specified in Table 1.
Biotinylated secondary antibodies were applied at 1:1000
dilution. Proteins were visualized by using diaminobenzidine
peroxidase (DAB) substrate (Invitrogen, Carlsbad, CA). Slides
were counterstained with hematoxylin. For immunofluores-
cent staining, secondary antibodies were applied at 1:500
dilution and slides were counterstained by 4′,6-diamidino-
2-phenylindole (DAPI).
Cell culture study
Human pancreatic ductal epithelial (HPDE) (Furukawa et al.,
1996; Ouyang et al., 2000) cells were cultured in keratinocyte
serum-free media supplemented with bovine pituitary extract
and human epidermal growth factor (Invitrogen). Control
vector (pCMV-SPORT6) and TFF1-overexpression plasmid
(Thermo Fisher Scientific) were transfected into HPDE cells
using FuGene6 (Roche) according to the manufacturer's
protocol.
In vitro migration assay
After the transfection of TFF1 and control vector, an artificial
wound was created by manually scraping confluent monolayerFigure 1 Tag and chase reveals a dynamic shift of PDG cells. (A) M
(arrow) but not in ductal epithelium (arrowhead), while KRT7 is expr
the principal site of proliferation. In response to injury, there is
expression of the proliferative marker Ki-67. (C) Scheme of BrdU tag
cells on day 0, and mouse pancreata were harvested daily over the
cells. BrdU tags PDG cells (arrow) initially, then tagged cells migrat
lumen (arrowhead). Double staining of BrdU and Ki67 shows that do
the typical dynamics of BrdU positive cells, which migrate from the c
of BrdU-positive cells shows a dynamic shift of BrdU-positive cells fr
(arrow) remain in PDGs for up to 21 days. Original magnification ×2cells with micropipettes tips. Dishes were incubated for 24 h
and the status of the gap closure was observed. 20 images
were acquired randomly and analyzed quantitatively by
calculating the cell-empty area using ImageJ (public domain
NIH image software).Cell proliferation assay
HPDE cells were planted on 96-well plates (1000 cells per well),
followed by the transfection of control, TFF1-overexpressing
plasmid. Five days after transfection, relative cell number was
calculated by resazurin (R&D Systems) using plate reader
(Spectramax M2, Molecular Devices) according to the manu-
facturer's protocol.RT-PCR
Total RNA (1 μg) was extracted from cultured cells using an RNA
extraction kit (RNeasy Mini; Qiagen) and used to synthesize
cDNA (ThermoScript PT-PCR System; Invitrogen). PCR amplifi-
cation was performed in a total volume of 50 μl containing 2 μl
of cDNA, 2 mM MgCl2, 200 μM dNTP Mix, 0.2 μM each of 5′- and
3′-primers, and 1U of PlatinumTaq DNApolymerase (Invitrogen)
with an annealing temperature of 60 °C. The sequence of the
TFF1 primers is 5′-CAGACAGAGACGTGTACAGTGGCCC-3′ (for-
ward) and 5′-AGCGTGTCTGAGGTGTCCGGT-3′ (reverse). The
number of PCR cycles was 34. For each reaction, an initial
denaturation cycle of 94 °C and a final cycle of 72 °C were
incorporated. The PCR products were subjected to 1% agarose
gel electrophoresis and stained with ethidium bromide. 18S
RNA was used as internal control.olecular characteristics of PDGs. MUC6 is expressed only in PDGs
essed in ductal epithelium but not in PDGs. (B) PDGs (arrow) are
a marked up-regulation of BrdU incorporation and increased
-and-chase experiment. BrdU was injected to mark proliferating
chase period of 7 days. (D) Qualitative analysis of BrdU-tagged
e out into duct epithelium, and some of them are shed into the
uble-positive cells were found only on day 0. The intestine show
rypt toward the surface then disappear. (E) Quantitative analysis
om PDGs to the ductal epithelium. (F) A few BrdU-positive cells
00 (except for intestine; ×100).
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Approximately 1000 cells from PDGs and pancreatic main duct
epithelium from two organ donors were laser captured and
microdissected with Arcturus PixCell IIe. RNA was purified
using an RNeasy Micro Kit (Qiagen) and amplified with the
Ovation® PicoSL WTA System V2 (NuGEN Technologies). RNA
isolated from cells obtained by LCM was quantified using a
nanodrop (Thermo Scientific) and RNA quality was assessed
using a Bionanalyzer (Agilent Technologies). Amplified RNA
was labeled with Encore™ BiotinIL Module (NuGEN Technolo-
gies) and hybridized to the HumanHT-12 v4 Expression
BeadChip (Illumina). Up-regulated genes in PDGs compared
to themain duct were filtered using a cut off of p ≤ 0.05 and a
fold change ≥ 1.5 for both organ donors. Analysis was per-
formed using GSEA (http://www.broadinstitute.org/gsea/
index.jsp). Gene expression data from intestine (GSE10629)
and colon (GSE6894) was analyzed with GEO2R (http://www.
ncbi.nlm.nih.gov/geo/geo2r/). Up-regulated genes in intes-
tinal crypts vs. intestinal villi and colon crypt bottom vs.
top were determined by p ≤ 0.05 and fold change ≥ 2. PDG
gene expression values were visualized with Gene Pattern
HeatMapImage (http://www.broadinstitute.org/cancer/
software/genepattern/).
Statistics
All statistical analysis was performed using SPSS-II software.
Differences between the two groups were analyzed using
ANOVA. When the P-value was ≤0.01, the difference was
regarded as significant.
Results
PDGs are the principal site of epithelial regeneration
of the pancreatic ductal epithelium
PDGs are gland-like outpouches budding off the main
pancreatic duct. These glands reside in the mesenchymal
cuff that surround larger pancreatic ducts. PDGs are
identified to be uniquely different form the overlying
pancreatic epithelium not only by morphology and location
but also by their molecular signature (Strobel et al., 2010).
For example MUC6 is strongly expressed in PDGs but not in
ductal epithelium, while KRT7 is not expressed in PDGs but is
in ductal epithelium (Fig. 1A). The normal pancreatic ductal
epithelium has a low rate of proliferation. Cerulein pancre-
atitis results in inflammatory injury to the pancreatic
epithelium with inflammatory cells around the ducts and
within the pancreatic epithelium (Fig. S1). In response toFigure 2 TFF are expressed in injured PDGs. (A, B) Immunohisto
normal pancreata, TFF1 is expressed at a low level and identified
compartment (arrow). Similarly, TFF2 is expressed at a very low l
expression is significantly up-regulated. While TFF1 expression is
expression distribution is restricted to the PDG compartment. Origina
analysis of TFF-positive PDGs in mouse and human specimen. Bot
pancreas (TFF1: 18.8% and 87.7% (mouse), 19.4% and 84.7% (human
control and pancreatitis, respectively). Data are shown as means +/acute inflammatory injury there was, as previously report-
ed, a 40% BrdU incorporation into the acinar cells (Strobel
et al., 2007a), however, there was also a marked up-
regulation of BrdU incorporation and increased expression of
the proliferative marker Ki-67 in the epithelia, identified
predominantly within the PDG compartment (Fig. 1B). In
order to establish PDGs as the site of epithelial ductal
regeneration and renewal, in vivo BrdU tag-and-chase
experiments were employed to fate-map tagged cells. In
this model (Fig. 1C) proliferating cells are pulse-labeled with
BrdU on day 0 after acute inflammatory injury; then pancreata
were harvested daily over the chase period of 7 days and then
at 14 and 21 days. Qualitative (Fig. 1D) and quantitative
(Fig. 1E) analyses revealed a dynamic shift of BrdU-positive
cells from the PDGs to the ductal epithelium over the chase
period. There was a gradual decline in the number of BrdU-
positive cells within the PDG compartment, from a peak of 25%
on day 0 to 5% by day 6 (Fig. 1D, E). Interestingly, some cells
within the PDG compartment retain their label even up to
21 days (1.06% of PDG cells; Fig. 1F). In contrast, BrdU cells
within the pancreatic ductal compartment gradually in-
creased from its baseline of 2.5% on day 0 to a peak of 12.5%
on day 5. By day 4, BrdU-tagged cells were identified on the
top of stratified epithelia (Fig. 1D, arrowheads), suggesting
that these cells are being shed into the lumen. By day 6, the
majority of the BrdU-tagged cells were no longer identified
within the pancreatic ducts.
In order to determine if the BrdU-label is lost by con-
tinued proliferation after the initial tagging event or after
migration into the pancreatic duct, double immunostaining
for Ki-67 and BrdU was performed. In this model, BrdU
detects cells that were proliferating during the initial tag
and Ki-67 detects cells presently proliferating (Fig. 1D).
While double-positive nuclei are found within the PDG
compartment on day 0, over the chase period BrdU-positive
cells are not found to be Ki-67 positive. Ki-67 cells can
occasionally be found in the PDG compartment after day 0,
but not in previously tagged BrdU cells. This data suggests
that cells in the PDG compartment generate their descen-
dants for only a restricted period of time, just after
inflammatory injury. Furthermore, these descendants (mi-
grated BrdU-positive cells) do not continue to proliferate.
These results suggest that PDGs are the compartment from
which newly generated cells migrate to regenerate and
renew the pancreatic ductal epithelia.
Migration of pancreatic epithelial cells is regulated
by TFF
The trefoil factor family (TFF), a family of protease-resistant
secreted factors, plays an essential role in epithelialchemistry of TFF1 and TFF2 in mouse and human specimens. In
in only a few cells throughout the ductal epithelium and PDG
evel. In response to inflammatory injury, both TFF1 and TFF2
found in both PDGs and duct epithelium (arrowhead), TFF2
l magnification ×400 (mouse), ×200 (human) (C, D) Quantitative
h TFF1 and TFF2 are expressed significantly higher in injured
); TFF2: 55.0% and 80.9% (mouse), 54.8% and 74.2% (human) in
− SD. (* p b 0.01).
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members to the migration of epithelial cells from the PDGs
to themain duct, immunohistochemistry of TFF1 and TFF2wasperformed in both mouse and human pancreata (Fig. 2A and
B). In normal pancreata, TFF1was expressed at a low level and
identified in only a few cells throughout the ductal epithelium
196 J. Yamaguchi et al.and PDG compartment (18.8% in normal mice, 19.4% in human
organ donors). Similarly, TFF2 is expressed at a very low level,
but its expression is restricted to the PDG compartment,
where it is identified in almost half of the PDGs (55.0% in
normal mice, 54.8% in human organ donors). In response to
inflammatory injury, TFF1 and TFF2 expression is significantly
up-regulated. The up-regulation of TFF1 is evidenced not only
by the enhanced staining within the PDGs and surrounding
pancreatic ductal epithelium, but also by a significant increase
(p b 0.001) in the total number of TFF1-positive PDGs (87.7%
in mice and 84.7% in humans) (Fig. 2C and D). Similarly, TFF2
shows enhanced staining as well as a statistically significant
increase (p b 0.01) in the total number of TFF2-positive PDGs
(80.9% in mice and 74.2% in human samples). TFF2 expression
remains restricted to the PDG compartment after the
inflammatory injury (Fig. 2A and B).
To determine whether TFF1 and TFF2 contribute to
pancreatic epithelial cell migration, in vivo pulse chase
experiments and in vitro migration assays were performed
(Fig. 3). To evaluate the role of TFF2 in cell migration, we took
advantage of a genetically engineered mouse deficient in
TFF2 (TFF2-KO). In vivo pulse-chase experiments on TFF2-KO
animals were repeated as previously described in normal
mice. Qualitative (Fig. 3A) and quantitative (Fig. 3B) analyses
revealed that the PDG compartments are the principal site of
proliferation and have a peak frequency of 25% of tagged PDG
cells on day 0 after inflammatory injury, which is similar to the
tagging efficiency seen in normal controls. However, over the
chase period of 7 days there was no dynamic shift of
BrdU-positive cells from the PDGs to the ductal epithelium.
Pulse-chase experiments in TFF2KO animals revealed a
persistence of BrdU label in the PDG compartment and no
increase in BrdU-labeled cells in the ducts. These mice not
only reveal decreasedmigration of cells from the PDGs but also
contain ulcerations of the main duct. These ulcerative lesions
were initially seen on day 3 and became more pronounced by
days 5–7 (Fig. 3A). These experiments demonstrate that the
loss of TFF2 decreases migration (not proliferation), resulting
in insufficient epithelial repair and ulceration.
In the absence of an available animal model, in vitro
migration experiments were performed in order to determine
the role of TFF1 in pancreatic ductal epithelial cell migration.
HPDE cells were transfected with either control, or TFF1-
expression vector and migration was evaluated by creating a
cell free area, an artificial “wound”, on confluent HPDE cells
(Fig. 3C and D). Transfection efficiency of the TFF-1 was
approximately 50%. Migration of cells to the cell-free region
was observed at 24 h and images were captured (Fig. 3D).
While HPDE with control vector shows 50% closure of the
cell-free region, TFF1-transfected cells are found to signifi-
cantly enhance migration ability (Fig. 3E; 70% of the cell-Figure 3 Migration of pancreatic ductal epithelial cells is regu
experiments on TFF2-KO mice. BrdU-positive cells remain in the
Ulceration of the pancreatic duct can be seen on day 5 and day 7 (
BrdU-tagged cells. (C) HPDE cells were transfected with control
confirmed by RT-PCR. (D) TFF1-HPDE cells migrate into artificial w
of the “cell-empty area.” TFF1-transfected cells resulted in a s
(F) Proliferative activity of HPDE cells by resazurin assay. TFF1-tranempty areawas healed, p b 0.0001). To exclude the possibility
that this healing of the cell free area was due to cell
proliferation rather than cell migration, the ability of cell
proliferation was assessed by resazurin assay (Fig. 3F).
TFF1-expressing HPDE cells show proliferative activity similar
to control, suggesting that the in vitro cell free area was
healed by the migration of the cells, rather than cell
proliferation. Together, the in vitro and in vivo data suggests
that up-regulation of TFF1 and TFF2 seen in the PDGs and in the
normal ductal epithelia likely functions to promote migration.
PDGs give rise to differentiated progeny
Stem cell niches are not only characterized by the presence
of proliferative compartments from which cells migrate;
these compartments must also have the ability to give rise to
mature differentiated progeny distinct from the parent
progenitor. Thus if PDGs are pancreatic ductal epithelial
progenitor niches, migrated BrdU-positive epithelial cells
found in the pancreatic ducts should express molecular
markers unique from BrdU-positive cells of the PDGs. In
order to evaluate the differentiation of PDG cells during
their migration, double IHC and IF were performed. Before
migration, BrdU-positive cells within the PDG compartment
express Alcian blue-positive mucin, TFF2 and deep gastric
mucin (Muc6) (Fig. 4, left panel, arrow). After migration,
BrdU-positive cells in the ductal epithelium have lost their
expression of these PDG markers (Fig. 4, arrowhead), and
have acquired the expression of a mature pancreatic duct-
specific marker, KRT7, which was not expressed in the PDG
compartment. Although these findings remain to be confirmed
with formal lineage tagging experiments, the changes in
molecular characteristics of BrdU-tagged cells suggest that
PDGs are capable of producing differentiated progeny,
supporting its role as a progenitor epithelial niche.
Microarray analysis reveals that the PDGcompartment
expresses stem cell markers
Minimal sample microarray analyses from LCM of PDG epithe-
lium compared to theirmatched normal pancreatic ducts reveal
that PDG cells are enriched for previously identified stem cell
genes (Fig. 5). Differentially expressed genes were identified
using a p ≤ 0.05 and a ≥1.5-fold change (Table S1). Gene Set
Enrichment Analysis (GSEA) revealed that the SOX2 and NANOG
pathways, core regulators of embryonic stem cell (ECS)
pluripotency, were enriched in the PDG compartment
(Fig. 5A). GSEA analysis identified 33 SOX2 and 36 NANOG
target genes are up regulated in PDGs (Table S2). Comparing our
PDG data set with other published stem cell data sets, we foundlated by TFF. (A) Qualitative analysis of in vivo pulse-chase
PDG (arrow) compartment over the chase period of 7 days.
arrowhead). (B) Quantitative analysis shows no dynamic shift of
and TFF1-expression vector. The transcriptions of TFF1 were
ound more rapidly than control cells. (E) Quantitative analysis
ignificantly smaller empty area (53.8% vs 29.6%, * p b 0.01).
sfected cells show no difference in proliferative activity.
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Figure 4 PDGs give rise to differentiated progeny. Identification of molecular characteristics of BrdU-tagged cells before migration
(day 0, arrow) and after migration (day 5, arrowhead) in mouse. During their migration, BrdU-tagged cells lose their initial expression
of PDG-specific markers (Alcian blue, TFF2 and Muc6) but acquire the expression of a mature pancreatic duct-specific marker, KRT7.
Original magnification ×400.
198 J. Yamaguchi et al.that PDGs were also enriched for genes found in intestinal and
colonic stem cells (Fig. 5B). In order to validate the GSEA
analysis, IHC was performed on human specimens for the two
core regulators pathways enriched in the PDG microarray. Both
SOX2 and NANOG were identified by IHC in the PDG compart-
ment. This low level of expression was identified in a subset of
cells within the PDG compartment (Fig. 5D). This data suggests
that SOX2 and the NANOG and/or their downstream effector
pathwaysmay play a role in the regulation of this compartment.
Thus this lineage-restricted progenitor compartment expressesseveral markers known to be important in embryonic and
somatic stem cell compartments. Of note, LGR5 was not
identified in our PDG microarray analysis; however, because it
is a well-characterized stem cell marker in the stomach and
intestine, we did investigate its expression. Both IHC of LGR5
and the analysis of Lgr5-eGFP mice also failed to identify Lgr5
expression in the PDG compartment (data not shown),
suggesting that progenitor cells within the PDGs do not express
Lgr5. Interestingly, the compartment also was found to be
enriched for pathways known to be important in pancreatic
Figure 5 Microarray analysis of RNA from PDGs and main duct epithelium of normal pancreas. (A) Gene set enrichment analysis
(GSEA) using the 424 genes up-regulated in PDGs demonstrates significant enrichment of Sox2 and Nanog target genes, as well as
genes with altered expression in pancreatic cancer. The gene set name, number of PDGs up-regulated genes in the gene set, and
p-value are shown. (B) Venn diagram comparing genes enriched in PDGs and the crypts of the intestine and colon. (C) Heatmap
representation of genes enriched in PDGs that are also enriched in intestinal and/or colon crypts. Genes implicated in the biology of
stem or progenitor cells are denoted by an asterisk. (D) The expression of SOX2 and nanog in PDG compartment were confirmed within
PDGs (arrow). Inlet shows higher magnification of positive cells.
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200 J. Yamaguchi et al.cancer (Table S2), suggesting not only that this compartment is
a progenitor niche but that dysregulation of the PDG compart-
ment may result in pancreatic malignancy.Discussion
The existence of somatic stem cells in the pancreas and their
contribution toward pancreatic epithelial renewal and regen-
eration after injury are poorly understood. Here we report
that PDGs, a novel epithelial compartment (Strobel et al.,
2010), function as a pancreatic ductal epithelial progenitor
niche. This work reveals that the PDGs are the principal site
of epithelial proliferation and new cell formation. In vivo
tag-and-chase experiments reveal that these newly generated
cells migrate from the PDGs to populate the pancreatic ductal
epithelium. Furthermore, this compartment is capable of
giving rise to differentiated progeny distinct from the parent
cell. The genes expressed in this unique compartment are
found to be enriched for core regulators of embryonic stem
cell pluripotency and genes important in intestinal and colonic
stem cells regulation. Taken together, this data suggests that
the PDGs are a progenitor stem cell compartment responsible
for pancreatic ductal epithelial regeneration.
The pancreas may employ several regenerative mecha-
nisms, depending on the compartment. Like the liver, the
pancreatic acinar and beta cell compartments regenerate
by self-duplication. Although a population of ALDH1
centroacinar/terminal ductal cells has been identified and
found to have multipotential function (Rovira et al., 2010), in
vivo lineage tagging studies by our group and others
demonstrate that the principal mode of regeneration of the
islets and acinar compartment in response to inflammatory
injury is dependent not on stem cells but rather on
self-duplication (Strobel et al., 2007a, 2007b; Dor et al.,
2004). The pancreatic ductal epithelium, however, appears toFigure 6 PDGs and GI stem cell niches share similar organization
glands of the stomach (left).bemore like the gastrointestinal epithelium, relying on a stem
cell niche for regeneration.
Although BrdU incorporation and the tag-and-chase
experiment suggest that the pancreatic ductal epithelium
is regenerated from the PDG compartment, this methodol-
ogy does have limitations and lineage tagging studies will
ultimately be needed to make definitive conclusions. In this
inflammatory model the pancreatic epithelium has several
proliferating (BrdU incorporating) compartments: the PDGs
(found in the proximal and central pancreatic ductal
epithelium), the terminal ducts, islets and the acinar cells.
In vivo lineage tracing of the acinar and beta cell com-
partments reveals that tagged events were never identified
in the pancreatic ductal epithelium, suggesting that neither
the acinar cells nor the beta cells are capable of
regenerating the ductal epithelium (Strobel et al., 2007a,
2007b). The PDGs appear to be important in regenerating
the proximal to distal pancreatic ductal epithelium. Howev-
er, the pancreatic epithelium is heterogeneous, and the
contribution of the PDGs to regeneration of the terminal
ducts remains unknown. Although PDGs have been found
throughout the pancreas, PDG-like cells have not been
identified in the terminal duct system (Strobel et al., 2010).
In response to inflammatory injury, terminal ducts them-
selves possess a high proliferative rate (Strobel et al.,
2007a); thus the mechanism of regeneration of the terminal
ducts likely does not rely on the PDG compartment.
PDGs possess a specific architecture and molecular
signature that make them distinct from the pancreatic
epithelium, instead resembling gastric stem cell glands.
PDGs were also found to express and up-regulate TFF genes
during injury. In the stomach TFF1 is normally found pre-
dominantly in the epithelium of the surface pit of the
stomach and TFF2 is primarily present in the neck region of
the antral and pyloric glands of the stomach. TFF and mucins
are co-expressed in gastric mucosa, such that MUC6/TFF2and function. Comparisons between PDGs (right) and the antral
201Pancreatic duct glands are responsible for pancreatic ductal epithelial repairare confined to the basal part of the gastric gland (Taupin
and Podolsky, 2003; Longman et al., 2000). This distribution
of TFF2 and co-expression of MUC6 are also seen in the PDG
niche. This molecular signature and the cellular organization
and proliferative activity within the PDGs are reminiscent of
the GI crypts/glands, most specifically the antral gland of
the stomach (Fig. 6). The similarities between the gastric
glands and PDGs may also extend to their functional roles
in regeneration and repair in response to inflammatory
injury. In stomach, the induction of trefoil-gene transcrip-
tion occurs early after inflammatory injury and is considered
to be important in migration of epithelial cells (FitzGerald
et al., 2004; Greeley et al., 2010). In the PDGs we also see
an up-regulation of TFF1 and TFF2. Although the functional
role of TFF in the pancreas is still not fully elucidated, our
work suggests that TFF1 and TFF2 play an important role in
regulating cell migration from the PDG compartment.
Stem cell niches in the GI system are also known to
contain several different populations of cells, including
actively dividing stem cells, transient amplifying cells (TA),
and label-retaining cells (LRC). TA cells will actively divide,
expanding the epithelial population for a defined period of
time, while LRC have a low rate of proliferative activity but
become activated during injury to be reverse stem cells
(Blanpain et al., 2007; Hoffmann, 2008; Li and Clevers, 2010;
Shaker and Rubin, 2010). The experiments described in our
study suggest that the PDG compartment is likely composed
of two populations of proliferating cells. There appears to be
one population of rapidly dividing cells whose presence is
demonstrated by the persistence of Ki-67. Thus a proportion of
the proliferating cells found in PDGs behave like transient
amplifying cells. The second population of cells has a much
lower rate of proliferation and will initially tag, retain their
BrdU label, and stay within the PDG compartment. These cells
are similar to the label-retaining cells (LRC) initially described
by Bickenbach in 1981 (Bickenbach, 1981). Given that only 1%
of PDG cells were found to be slowly dividing cells, most of the
cells tagged by BrdU are short-lived progenitors. Although the
exact functional role of these cells remains to be determined,
what is clear is that this compartment is composed of cells
with differing proliferative potential.
Stem cells and cancer share many properties. Mutations or
dysregulation of pathways within the stem cell compartment
are thought to contribute to the formation of cancer. One
example is the Hedgehog (Hh) pathway, which has been shown
to play a role in lineage determination, maintenance of stem
cell niches, and pancreatic regeneration (Strobel et al., 2010;
Fendrich et al., 2008). Its aberrant up-regulation is found in
PDAC specifically within the pancreatic cancer stem cells
(CSC) (Thayer et al., 2003; Li et al., 2007). It is interesting to
note that cells in the PDG progenitor niche and pancreatic
cancer stem cells (CSC) share similar features. Our GSEA
microarray analysis not only identified this compartment to be
enriched for stem cell pathways; it also showed it to be
enriched for pathways dysregulated in pancreatic cancer.
Althoughmuch work needs to be done to determine the role of
the PDGs as the site of origin for pancreatic neoplasia, what
this work does reveal is that the PDGs are the site of epithelial
proliferation from which differentiated progeny migrate to
regenerate and renew the pancreatic epithelium in response
to inflammatory injury. Thus PDGs are an epithelial progenitor
niche important for pancreatic ductal epithelial regeneration.Abbreviations
PDGs pancreatic duct glands
TFF trefoil factor family
CSC cancer stem cells
CK cytokeratin
LCM laser capture microdissection
IF immunofluorescence
IHC immunohistochemistry
LRC label-retaining cells
TA transient amplifying cells
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